ArticleJournal of pediatric gastroenterology and nutrition2026

Multicenter experience using tofacitinib for treatment of refractory pediatric inflammatory bowel diseases in the United States.

Denise D Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.